Literature DB >> 17113733

Influence of carrier on the performance of dry powder inhalers.

G Saint-Lorant1, P Leterme, A Gayot, M P Flament.   

Abstract

The aim of this work is to study carriers which can become alternatives to monohydrate lactose in dry powder inhalers and to consider particle parameters that influence adhesion between drug and carrier in dry powder inhalers. Different forms of mannitol, lactose and maltitol were mixed with either terbutaline sulphate or formoterol fumarate. The blends were submitted to different adhesion tests where drug detachment from the carrier was obtained either through mechanical vibration or by aspiration. Parameters like particle shape, roughness, amorphous content and cristalline form may affect interactions between drug and carrier. In our case, crystallized forms of the carrier offered lower adhesion but better release of the active ingredient than spray-dried forms. The crystallized mannitol produced maximal fine particle dose. The blends of the mannitols and the two active ingredients gave different results. The two techniques used to assess the adhesion of drugs to carrier particles provide complementary information about drug/carrier interactions and detachment. The mechanical sieving allows to assess blend stability and the air-jet sieving makes it possible to determine how easily the drug separates from carrier. For the drugs tested, the results of fine particle doses are in agreement with the Alpine air-jet sieve results. The tests used are helpful for the choice of a new carrier in the field of the development of new carriers for dry powder inhalers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113733     DOI: 10.1016/j.ijpharm.2006.10.028

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Dry powder inhalers: study of the parameters influencing adhesion and dispersion of fluticasone propionate.

Authors:  V N P Le; T H Hoang Thi; E Robins; M P Flament
Journal:  AAPS PharmSciTech       Date:  2012-03-08       Impact factor: 3.246

Review 2.  Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities.

Authors:  Sharad Mangal; Wei Gao; Tonglei Li; Qi Tony Zhou
Journal:  Acta Pharmacol Sin       Date:  2017-05-01       Impact factor: 6.150

3.  Fragmented particles containing octreotide acetate prepared by spray drying technique for dry powder inhalation.

Authors:  Ailin Hou; Lu Li; Ying Huang; Vikramjeet Singh; Chune Zhu; Xin Pan; Guilan Quan; Chuanbin Wu
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

Review 4.  Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.

Authors:  Andrew M Shen; Tamara Minko
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

5.  Towards a more desirable dry powder inhaler formulation: large spray-dried mannitol microspheres outperform small microspheres.

Authors:  Waseem Kaialy; Tariq Hussain; Amjad Alhalaweh; Ali Nokhodchi
Journal:  Pharm Res       Date:  2013-08-06       Impact factor: 4.200

6.  Development of Budesonide Loaded Biopolymer Based Dry Powder Inhaler: Optimization, In Vitro Deposition, and Cytotoxicity Study.

Authors:  Ashwin J Mali; Atmaram P Pawar; Ravindra N Purohit
Journal:  J Pharm (Cairo)       Date:  2014-06-15

7.  Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.

Authors:  Chutima Sinsuebpol; Jittima Chatchawalsaisin; Poj Kulvanich
Journal:  Drug Des Devel Ther       Date:  2013-08-28       Impact factor: 4.162

8.  Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy.

Authors:  Zitong Shao; Waiting Tai; Yingshan Qiu; Rico C H Man; Qiuying Liao; Michael Y T Chow; Philip C L Kwok; Jenny K W Lam
Journal:  Pharmaceutics       Date:  2021-11-30       Impact factor: 6.321

9.  Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids.

Authors:  Wanling Liang; Philip C L Kwok; Michael Y T Chow; Patricia Tang; A James Mason; Hak-Kim Chan; Jenny K W Lam
Journal:  Eur J Pharm Biopharm       Date:  2013-05-20       Impact factor: 5.571

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.